About the Company
Mylan NV is a pharmaceutical healthcare company. The firm engages in the development, license, manufacture, market and distribution of generic, branded generic and specialty pharmaceutical products. It operates through the following geographical segments: North America, Europe and Rest of World. The North America segment develops, manufactures, sells, and distributes pharmaceutical products in tablet, capsule, injectable, transdermal patch, gel, nebulized and cream, or ointment form. The Europe segment operates through subsidiaries in Italy, Germany, the United Kingdom, and Spain. The Rest of World segment comprises of operations in Japan, Australia, China, Brazil, Russia, India, South Africa, Middle East and South East Asia. The company was founded in 1961 and is headquartered in Hatfield, the United Kingdom.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $MYL News
Mylan (MYL) Stock Climbs on $1 Billion Stock Buyback
Separately, TheStreet Ratings team rates MYLAN NV as a Buy with a ratings score of B-. TheStreet Ratings Team has this to say about their recommendation: We rate MYLAN NV (MYL) a BUY. This is ...
Mylan (MYL) Stock Falls After Shareholders Approve Hostile Takeover of Perrigo
Perrigo shares are are down 1.72% to $184.96 this afternoon. Separately, TheStreet Ratings team rates MYLAN NV as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about ...
Mylan, Lupin said to weigh bids for Bayer dermatology unit
LONDON: Drugmakers including Mylan NV and Lupin Ltd are considering bids for Bayer AG’s dermatology business as the German company sells assets ahead of its US$66bil acquisition of Monsanto Co ...
Azithromycin Mylan
This leaflet answers some common questions about AZITHROMYCIN MYLAN. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist.
CVS offers generic competitor to EpiPen
That often forces patients to fill new prescriptions even if they never used the old one. Mylan NV started taking heat late last summer for its EpiPen pricing, which has climbed more than 500 ...
Theravance, Mylan settle patent litigation over COPD drug Yupelri
Theravance and Mylan had sued Teva over its attempts to market a generic version of Yupelri, also known as revefenacin, before the drug's Orange Book-listed patents had expired. The deal is ...
Theravance Biopharma, Mylan settle patent dispute over Yupelri
The settlement comes as Theravance and Mylan, which joined Pfizer spinoff Upjohn in 2020 to establish Viatris , are fighting ...
Death Notices
Bernardus Simons, 88, Vancouver, died April 6, 2024. Hamilton-Mylan Funeral Home, 360-694-2537. Diana J. James, 72, Vancouver, died April 11, 2024. Brown’s Funeral ...
Las Vegas, NV
Las Vegas is renowned as a resort city for gambling, shopping, and fine dining. Billing itself as "The Entertainment Capital of the World," it is famous for its casino resorts and various forms of ...
DOJ: Mylan, Other Companies Pay $124 Million To Settle Medicaid Case
Mylan Inc. (MYL) and other drug makers have paid $124 million to settle charges that they underpaid their rebate obligations to state Medicaid programs, the U.S. Justice Department announced ...
Henderson, NV
Las Vegas suburb of 293,000. Median home price $314,000. Cost of living 13% above national average. PROS: Low serious crime rate. No state income tax. No state estate/inheritance tax. CONS: Low ...
UPDATE: Mylan Swings To 3Q Loss On Charges; Upgrades 2009 EPS View
Mylan Inc. (MYL) swung to a third-quarter loss, weighed down by litigation and acquisition-related expenses, as its core operational performance exceeded Wall Street expectations. The Pittsburgh ...
Loading the latest forecasts...